Lilly removes Xigris from market
INDIANAPOLIS — Eli Lilly is withdrawing one of its drugs from the market after clinical trials showed it to be ineffective.
The drug maker announced Tuesday the withdrawal of Xigris (drotrecogin alfa [activated]) from all markets following results of the "PROWESS-SHOCK" study, which found that it did not produce a statistically significant reduction in 28-day, all-cause death in patients with septic shock. The company said there were no new findings regarding the drug’s safety profile.
The drug was used to treat sepsis, a common and deadly disease that can develop as a complication after such illnesses as bacterial infections and pneumonia, and results from an overwhelming systemic response to infection that can lead to organ failure and death.
"[The] study failed to demonstrate that Xigris improved patient survival and thus calls into question the benefit-risk profile of Xigris and its continued use," Lilly SVP and chief medical officer Timothy Garnett said. "Patients currently receiving treatment with Xigris should have treatment discontinued, and Xigris treatment should not be initiated for new patients."
CDC panel recommends HPV vaccination for boys
ATLANTA — An advisory committee of the Centers for Disease Control and Prevention is recommending that all boys ages 11 and 12 years old get vaccinated against human papillomavirus, the CDC said Tuesday.
The agency said the Advisory Committee on Immunization Practices voted for recommending routine vaccination of boys with three doses of HPV4 to protect against the virus. The vaccination is able to prevent such HPV-related conditions as cancer and prevent the spread of the virus to sexual partners. The recommendation is still subject to the CDC’s approval, the agency said.
The CDC already recommends the routine vaccination of girls and women ages 9 to 26 years against the virus.
Two HPV vaccines currently exist on the market: Merck’s Gardasil and GlaxoSmithKline’s Cervarix.
Baby Magic offers new solutions to pamper, protect little ones
DALLAS — Baby Magic, a family-owned baby care brand, has added four new products to its portfolio.
The four new products expand the Baby Magic line of treatment and bath items to include:
No-Rinse Wash: This wash, perfect for cleansing on-the-go, is specially formulated for baby’s sensitive skin and the self-foaming application allows for cleaning baby’s hair or skin without using water;
Kids Magic Bubble Bath: This tear-free, hypoallergenic formula is available in either Calming Lavender or Bubble Gum Pop;
Healing Balm — for Eczema: The balm is enriched with vitamins, aloe, oatmeal and shea butter to help with minor skin irritation and itching due to eczema, which currently affects 1-out-of-4 children. The balm features an easy stick application to target problem areas on the hands, face and body; and
Medicated Patty Cake: The patented Baby Magic Patty Cake cream-to-powder baby powder now comes in a medicated formula for children with extra sensitive skin. Unlike the original, this Patty Cake is a nongreasy, cream-to-powder formula for diaper rash treatment.
All products are hypoallergenic, paraben-free, gluten-free and produced in the United States.